Adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: results from CALGB 80101 (Alliance). J Clin Oncol 2017; 35: 3671-3677.

Published: 17th May 2018

Authors: Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Xing Y, Swanson RS et al.

Conclusion

Some 546 patients were included and followed for a median 6.5 years. The new regimen did not improve overall 5-year survival (44 per cent in both groups) or disease-free survival: 37 per cent, versus 39 per cent with standard chemotherapy.

Pubmed Link

Your comments

0 Comments